Chenglin Wu

机构：Shanghai Sixth People's Hospital · ORCID：0000-0002-0635-1122

发表论文 93 篇 · 总被引 1152 次 · h-index 17

代表论文

• Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients (2023 · Advanced Science · 被引 93)
• TREM2/β-catenin attenuates NLRP3 inflammasome-mediated macrophage pyroptosis to promote bacterial clearance of pyogenic bacteria (2022 · Cell Death and Disease · 被引 70)
• Peripheral nervous system microglia-like cells regulate neuronal soma size throughout evolution (2025 · Cell · 被引 43)
• Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer (2022 · Journal of Medicinal Chemistry · 被引 20)
• Novel substituted 4-(Arylethynyl)-Pyrrolo[2,3-d]pyrimidines negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGlu5) Treat depressive disorder in mice (2023 · European Journal of Medicinal Chemistry · 被引 11)
• The Outcome of Transplanting Kidneys From Very Small Pediatric Deceased Donors (2023 · Transplantation · 被引 10)